Extrawell Pharmaceutical Holdings Ltd
00858
Company Profile
Business description
Extrawell Pharmaceutical Holdings Ltd is an investment holding company. Its segments are the manufacturing segment engages in the development, manufacture and sales of pharmaceutical products; and the trading segment engages in the marketing and distribution of imported pharmaceutical products. It derives the majority of revenue from the Manufacturing segment. Its operations are located in the PRC and Hong Kong.
Contact
979 King’s Road
Suites 2206-08, 22nd Floor
FWD Tower, Taikoo Place
Quarry Bay
Hong Kong
HKGT: +852 28561918
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
158
Stocks News & Analysis
stocks
Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up
The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.
stocks
Takeover proposal agreed for ASX share, other offers permitted
Morningstar analysts’ take on the takeover for this undervalued industrial player.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,951.00 | 31.90 | 0.36% |
| CAC 40 | 8,187.97 | 49.03 | 0.60% |
| DAX 40 | 25,746.37 | 171.36 | 0.67% |
| Dow JONES (US) | 52,048.83 | 366.19 | 0.71% |
| FTSE 100 | 10,757.64 | 18.63 | 0.17% |
| HKSE | 25,087.75 | 45.04 | 0.18% |
| NASDAQ | 27,122.09 | 599.55 | 2.26% |
| Nikkei 225 | 65,018.95 | 882.70 | 1.38% |
| NZX 50 Index | 13,875.48 | 54.28 | 0.39% |
| S&P 500 | 7,764.70 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,757.80 | 25.90 | 0.30% |
| SSE Composite Index | 3,952.13 | 2.22 | 0.06% |